The novel HLA-A*11:01:124 allele was identified in a Chinese individual.

HLA

Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Published: January 2024

AI Article Synopsis

  • - The HLA-A*11:01:124 allele is a variation of the HLA-A*11:01:01 allele.
  • - The difference between these two alleles is due to a single nucleotide change.
  • - This nucleotide substitution occurs at position 459 in exon 3, specifically a C to T change.

Article Abstract

The HLA-A*11:01:124 allele differs from HLA-A*11:01:01 by one nucleotide substitution, (C > T) position 459 in exon 3.

Download full-text PDF

Source
http://dx.doi.org/10.1111/tan.15296DOI Listing

Publication Analysis

Top Keywords

hla-a*1101124 allele
8
novel hla-a*1101124
4
allele identified
4
identified chinese
4
chinese individual
4
individual hla-a*1101124
4
allele differs
4
differs hla-a*110101
4
hla-a*110101 nucleotide
4
nucleotide substitution
4

Similar Publications

Viral diseases severely impact maize yields, with occurrences of maize viruses reported worldwide. Deployment of genetic resistance in a plant breeding program is a sustainable solution to minimize yield loss to viral diseases. The meta-QTL (MQTL) has demonstrated to be a promising approach to pinpoint the most robust QTL(s)/candidate gene(s) in the form of an overlapping or common genomic region identified through leveraging on different research studies that independently report genomic regions significantly associated with the target traits.

View Article and Find Full Text PDF

Background: There is still no conclusive understanding of whether the glucokinase regulator (GCKR) gene rs780094 and rs1260326 polymorphisms predispose to gestational diabetes mellitus (GDM).

Objective: This systematic review and meta-analysis aimed to determine the effect of the GCKR polymorphisms on GDM susceptibility.

Methods: Seven literature databases were searched (from inception to February 17, 2024) to locate relevant studies included in further meta-analysis.

View Article and Find Full Text PDF

VEXAS syndrome is a haemato-inflammatory disease caused by somatic UBA1 mutations and characterized by cytoplasmic vacuoles in myeloid and erythroid precursor cells. Although there is currently no standard treatment algorithm for VEXAS, patients are generally treated with anti-inflammatory therapies focused on symptom management, with only partial effectiveness. Hypomethylating agents (HMA) have shown promise in VEXAS patients with concomitant myelodysplastic syndrome (MDS), while the efficacy of HMA in VEXAS patients without MDS is largely unknown.

View Article and Find Full Text PDF

Misfolding of the cellular PrP (PrP) protein causes prion disease, leading to neurodegenerative disorders in numerous mammalian species, including goats. A lack of PrP induces complete resistance to prion disease. The aim of this work was to engineer Alpine goats carrying knockout (KO) alleles of PRNP, the PrP-encoding gene, using CRISPR/Cas9-ribonucleoproteins and single-stranded donor oligonucleotides.

View Article and Find Full Text PDF

Background: The magnitude of inbreeding depression depends on the recessive burden of the individual, which can be traced back to the hidden (recessive) inbreeding load among ancestors. However, these ancestors carry different alleles at potentially deleterious loci and therefore there is individual variability of this inbreeding load. Estimation of the additive genetic value for inbreeding load is possible using a decomposition of inbreeding in partial inbreeding components due to ancestors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!